Form 13-F position report

AVADEL PHARMACEUTICALS PLC

Reported by MORGAN STANLEY

AVDL CUSIP G29687103 Manager CIK 0000895421

Reported 0 shares, down 529,074 (100.0%) from the prior quarter.

Reported value -100.0%; share count -100.0% vs. the prior quarter.

Reduced
% of reported 13F value 0 This manager · Q1 2026
Shares 0 Quarter-end amount reported
Reported value $0 Fair value at quarter end
Consecutive quarters held 8 Through Q1 2026

Reported position value by quarter

Reported position value by quarter

Each bar is a Form 13-F quarter-end snapshot. It does not show trades made within the quarter.

Reported position value by quarter
Date Holding Value
2024-06-30 11716367
2024-09-30 12438329
2024-12-31 12710757
2025-03-31 8101034
2025-06-30 10554572
2025-09-30 34490101
2025-12-31 11401549
2026-03-31 0

Quarterly position history

How this manager's reported quarter-end position changed over time.

8 quarters
Quarterly reported position history for AVADEL PHARMACEUTICALS PLC held by MORGAN STANLEY.
Quarter Activity Shares Change % of reported 13F Reported value Filed Source filing
Q1 2026 Reduced 0 -529,074 (-100.0%) 0 $0 2026-05-15
Q4 2025 Reduced 529,074 -1,729,609 (-76.6%) < 0.01% $11,401,549 2026-02-13
Q3 2025 Added 2,258,683 +1,066,077 (89.4%) < 0.01% $34,490,101 2025-11-14
Q2 2025 Added 1,192,606 +157,992 (15.3%) < 0.01% $10,554,572 2025-08-15
Q1 2025 Reduced 1,034,614 -174,782 (-14.5%) < 0.01% $8,101,034 2025-05-15
Q4 2024 Added 1,209,396 +260,992 (27.5%) < 0.01% $12,710,757 2025-02-14
Q3 2024 Added 948,404 +115,092 (13.8%) < 0.01% $12,438,329 2024-11-14
Q2 2024 New 833,312 +833,312 (0.0%) < 0.01% $11,716,367 2024-08-14

Who else reported the position

205 managers reported AVADEL PHARMACEUTICALS PLC for Q1 2026.

Managers reporting AVADEL PHARMACEUTICALS PLC in Q1 2026.
Manager Activity Shares Change % of reported 13F Reported value Tenure
IFP Advisors Inc Unchanged 20 0 < 0.01% $426 6 qtrs
Quantinno Capital Management LP Reduced 0 -41,611 0 $0 5 qtrs
HARVEST MANAGEMENT LLC Reduced 0 -300,000 0 $0 2 qtrs
Parkside Financial Bank & Trust Reduced 0 -50 0 $0 5 qtrs
Groupe la Francaise Reduced 0 -479,291 0 $0 2 qtrs
PRELUDE CAPITAL MANAGEMENT LLC Reduced 0 -31,694 0 $0 8 qtrs
1620 INVESTMENT ADVISORS INC Reduced 0 -290 0 $0 6 qtrs
Engineers Gate Manager LP Reduced 0 -11,357 0 $0 7 qtrs
Basecamp Wealth Advisors LLC Reduced 0 -8 0 $0 2 qtrs
Handelsbanken Fonder AB Reduced 0 -36,400 0 $0 4 qtrs
Premium adds each manager's conviction percentile across reporting peers.
Filing details and methodology As reported
Report period
March 31, 2026
Filed
May 15, 2026
Filing type
13F-HR
Position type
COM SHS

Voting authority reported

No voting-authority amounts were reported for this position. Voting authority is not required for reported call options.

Form 13-F is a delayed quarter-end snapshot of disclosed long Section 13(f) securities. It can be filed up to 45 days after quarter end, excludes short positions and most non-U.S. securities, and does not reveal intra-quarter trading. For options, reported shares and value describe the underlying-share exposure; strike, expiry, premium, and written positions are not disclosed.